This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Queen's University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,786,273
Fecal microbiota transplantation in combination with immune checkpoint blockade in patients with advanced melanoma: A randomized phase II trial
CIHR · 2023 · Principal investigator
Fecal microbiota transplantation in combination with immune checkpoint blockade in patients with advanced melanoma: A randomized phase II trial
Principal investigators: Dancey, Janet E; Elkrief, Arielle; Lenehan, John; Maleki, Saman; Routy, Bertrand; Silverman, Michael
Keywords: Fecal Microbiota Transplant; Melanoma; Microbiome; Multicentre; Phase Ii; Progression-Free Survival; Randomized Controlled Trial
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.